Our main analysis involves estimating logit regressions of the following form: {Prosocial}_{i}=alpha+beta {Public}_{i}+X_{i}'delta+mu_{c}+s_{t}+epsilon_{i}, (1).
For our main analysis we estimate individual fixed-effects models, as is frequently done when panel data are available.
Sample size was based on having a form of multiple regression as the main analysis to estimate associations with a continuous HRQoL outcome.
For our main analysis, we estimated the change in the incidence of anal sphincter tears before and after implementation of the intervention in the five intervention hospitals, taking into account the trends in the incidence of anal sphincter tears before and after implementation.
The main analysis employed estimates of distant recurrence risk from a Japanese validation study [ 17].
Compared with the main analysis, point estimates of the rate ratio of all cause mortality moved closer to the null effect line, and 95% credibility intervals became wider, with a rate ratio of 0.85 for coronary artery bypass grafting (0.72 to 1.00), 0.82 for everolimus eluting stent (0.65 to 1.03), and 0.71 for zotarolimus eluting (Resolute) stent (0.46 to 1.11) compared with medical treatment.
We employ the same strategy as in the main analysis: we first estimate parameters on data generated from single stochastic stimuli, and then fix the response kernel and estimate the other parameters on data generated from stochastic stimulus mixture.
In the main analysis, regressions are estimated separately by gender and separately for natives (those born in Sweden independently of where their parents are born), Western immigrants (those born in a Nordic country, within EU15 and in North America), and non-Western immigrants (those born elsewhere).
In our main analysis, overdiagnosis was estimated as 0.7% of screen-detected cancers.
One analysis estimates that asset-backed C.D.O.
